Fletcher JA: HLA associations with insulin-dependent diabetes mellitus, in Barnett AH (ed): Immunogenetics of Insulin-Dependent Diabetes. Lancaster, MTP Press, 1987.
2.
Stob H., Pesch HJ, Pontz B., et al: Wolcott-Rallison syndrome: Diabetes mellitus and spondyloepiphyseal dysplasia. Eur J Pediatr1982;138:120-129.
3.
Najjar SS, Saikaly MG, Zaytoun GM, et al: Association of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness: The Wolfram or DIDMOAD syndrome. Arch Dis Child1985; 60:823-828.
4.
Kretzschmar HA, Berg BO, Davis RL: Giant axonal neuropathy. A neuropathological study. Acta Neuropathol (Berl) 1987;73: 138-144.
5.
Ben Hamida M., Hentati F., Ben Hamida C.: Giant axonal neuropathy with inherited multisystem degeneration in a Tunisian kindred. Neurology1990;40:245-250.
6.
Kinney RB, Gottfried MR, Hodson AK, et al: Congenital giant axonal neuropathy. Arch Pathol Lab Med1985;109:639-641.
7.
Lampl Y., Eshel Y., Ben-David E., et al: Giant axonal neuropathy with predominant central nervous system manifestations. Dev Med Child Neurol1992;34:164-181.
8.
Ionasesou V. , Searby CH, Rubenstein P., et al: Giant axonal neuropathy: Normal protein composition of neurofilaments. J Neurol Neurosurg Psychiatry1983;46:551-554.
9.
Takebe Y., Koide N., Takahashi G.: Giant axonal neuropathy: Report of two siblings with endocrinological and histological studies. Neuropediatrics1981 ; 12:392-404.
10.
Origuchi Y. : Quantitative histological study in the sural nerves of children. Brain Dev1981;3:395-402.
11.
Vital C., Vallet J.: Ultrastructural Study of the Human Diseased Peripheral Nerve, 2nd ed. New York, Elsevier , 1987.
12.
Boltshauser E., Bischoff A., Isler W.: Giant axonal neuropathy: Report of a case with normal hair. J Neurol Sci1977;31:269-278.
13.
Tandan R., Little BW, Emery ES, et al: Childhood giant axonal neuropathy: Case report and review of the literature. J Neurol Sci1987;82:205-228.
14.
Ouvrier RA: Giant axonal neuropathy: A review. Brain Dev1989;11:207-214.
15.
La Porte RE , Fishbein HA, Drash AL, et al: The Pittsburgh insulin-dependent diabetes mellitus (IDDM) registry. The incidence of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania (1965-1976). Diabetes1981;30:279-284.
16.
Wolfe E., Spencer KM, Cudworth AG: The genetic susceptibility to type I (insulin-dependent) diabetes: Analysis of the HLA-DR association. Diabetologia1983 ;24:224-230.
17.
Rowley MJ, Mackay IR, Chen QY, et al: Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes1992;41:548-551.
18.
Dyck PJ, Zimmerman BR, Vilen TH, et al: Nerve glucose, fructose, sorbitol, myo-inositol and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med1988;319:542-548.
19.
Yasuda H., Dyck PJ: Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology1987;37:20-28.
20.
Dyck PJ, Karnes JL, O'Brien P., et al: The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol1986;19:440-449.
21.
Said G., Goulon-Goeau C., Slama G., et al: Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus: A clinical and pathological study. N Engl J Med1992;326:1257-1263.
22.
Young RJ, Macintyre CCA, Martyn CN, et al: Progression of subclinical polyneuropathy in young patients with type I (insulin-dependent) diabetes: Associations with glycaemia control and microangiopathy (microvascular complications). Diabetologia1986;29:156-161.
23.
Hoffman WH, Hart Z., Frank RN: Correlates of delayed motor nerve conduction and retinopathy in type I diabetes mellitus. J Pediatr1983;102:351-356.
24.
Ziegler D., Cicmir I., Mayer P., et al: Somatic and autonomic nerve function during the first year after diagnosis of type I (insulin-dependent) diabetes. Diabetes Res1988;7:123-127.
25.
Bongiovanni LG , Pinelli L., Cirillo D., et al: Assessment of autonomic functions in insulin-dependent diabetic children and adolescents . Funct Neurol1988;3:47-54.
26.
Sundkvist G. : Autonomic nervous function in asymptomatic diabetic patients with signs of peripheral neuropathy. Diabetes Care1981;4:529-534.
27.
Maia M., Pires MM, Guimaraes A.: Giant axonal disease: Report of three cases and review of the literature . Neuropediatrics1988;19:10-15.
28.
Gambarelli D., Hassoun J., Pellissier JF, et al: Giant axonal neuropathy: Involvement of peripheral nerve, myenteric plexus, and extra-neuronal area. Acta Neuropathol (Berl) 1977;39:261-269.
29.
Ewing DJ, Martyn CN, Young RJ, et al: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care1985 ;8:491-498.
30.
Krolewski AS , Barzilay J., Warram JH, et al: Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy . Diabetes1992;41:430-437.
31.
Brown FM, Brink SJ, Freeman R., et al: Anti-sympathetic nervous system autoantibodies. Diminished catecholamines with orthostasis. Diabetes1989;38:938-941.
32.
Biaggioni I. , Garcia F., Inagami T., et al: Hyporeninemic normoaldosteronism in severe autonomic failure. J Clin Endocrinol Metab1993;76:580-586.
33.
Akinci A., Celiker A., Baykal E.: Heart rate variability in diabetic children: Sensitivity of the time- and frequency-domain methods. Pediatr Cardiol1993; 14:140-146.
34.
Tsigos C., Young RJ, White A.: Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab1993;76:554-558.
35.
Jirmanova I. : Giant axonopathy in streptozotocin diabetes of rats. Acta Neuropathol (Berl) 1993;86:42-48.
36.
Davenport JG , Farrell DF, Sumi SM: Giant axonal neuropathy caused by industrial chemicals: Neurofilamentous axonal masses in man. Neurology1976;26:919-923.